Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole for Vulvovaginal Candidiasis in Japanese Patients
NCT01806623Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2013
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluconazole in vulvovaginal candidiasis (VVC), sponsored by Pfizer. Started Mar 2013; status: completed.
02
Drugs
fluconazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT01806623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806623.